53
Participants
Start Date
July 1, 2012
Primary Completion Date
September 1, 2014
Study Completion Date
September 1, 2014
Dapagliflozin
Tablet, Oral, 2.5 mg, Single-dose
Dapagliflozin
Tablet, Oral, 5 mg, Single-dose
Dapagliflozin
Tablet, Oral, 10 mg, Single-dose
Women And Children'S Hopsital Of Buffalo, Buffalo
Children'S Hospital Of Pittsburgh Of Upmc, Pittsburgh
Children'S Hospital Of Philadelphia, Philadelphia
Emory University, Atlanta
Nemours Childrens Hospital, Orlando
The Children Hospital Of Alabama, Birmingham
Methodist Le Bonheur Hlthcare, Memphis
Kosair Charities Pediatric Clinical Research Unit, Louisville
Promedica Toledo Children'S Hospital, Toledo
Mercy Children'S Hospital, Toledo
Local Institution, Guadalajara
Childrens Mercy Hospital, Kansas City
Local Institution, Monterrey
Lsuhsc-Shreveport, Shreveport
Christus Santa Rosa Childrens Hospital, San Antonio
Axis Clinical Trials, Los Angeles
Local Institution, Veracruz
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
AstraZeneca
INDUSTRY